View source for THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY patent applications published on March 21st, 2024

'''Summary of the patent applications from THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY on March 21st, 2024'''

The organization (THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY) has recently filed patents for innovative technologies in various fields:

- A system for implementing privacy-preserving smart contracts on a blockchain-based platform, ensuring confidentiality and anonymity while maintaining functionality with limited performance overhead.
- A method and apparatus for scanning in a field of view using a pattern that improves sensing in a region of interest within the field of view.
- Methods for treating subjects in need of IL-1 inhibitor therapy or IL-6 inhibitor therapy by determining the risk for drug-related hypersensitivity through HLA allele assays.
- Methods and compositions for treating SCID-X1 in subjects by genetically modifying cells ex vivo with a full-length, codon-optimized IL2RG cDNA at the endogenous IL2RG locus.

Notable applications of these technologies include:
- Secure financial transactions
- Enhanced surveillance systems
- Personalized medicine for tailored treatment plans
- Gene therapy for genetic disorders

These innovations address critical issues in privacy, sensing capabilities, drug-related hypersensitivity, and genetic disorders, offering potential benefits such as increased privacy, improved data collection, enhanced patient safety, and targeted treatment options.




==Patent applications for THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY on March 21st, 2024==

===METHODS OF MODULATING NEURONAL AND OLIGODENDROCYTE SURVIVAL ([[THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (18280126). METHODS OF MODULATING NEURONAL AND OLIGODENDROCYTE SURVIVAL simplified abstract|18280126]])===


'''Main Inventor'''

Shane LIDDELOW


===ENGINEERED PROTEINS TO ENHANCE SENSITIVITY OF A CELL TO IL-2 ([[THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (18460452). ENGINEERED PROTEINS TO ENHANCE SENSITIVITY OF A CELL TO IL-2 simplified abstract|18460452]])===


'''Main Inventor'''

Kenan Christopher Garcia


===MARKERS OF ACUTE MYELOID LEUKEMIA STEM CELLS ([[THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (18363584). MARKERS OF ACUTE MYELOID LEUKEMIA STEM CELLS simplified abstract|18363584]])===


'''Main Inventor'''

Ravindra Majeti


===CHEMICALLY REVERSIBLE 2`-OH ACYLATION PROTECTS RNA FROM HYDROLYTIC AND ENZYMATIC DEGRADATION ([[THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (18377236). CHEMICALLY REVERSIBLE 2`-OH ACYLATION PROTECTS RNA FROM HYDROLYTIC AND ENZYMATIC DEGRADATION simplified abstract|18377236]])===


'''Main Inventor'''

Linglan Fang


===GENE CORRECTION FOR SCID-X1 IN LONG-TERM HEMATOPOIETIC STEM CELLS ([[THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (18007439). GENE CORRECTION FOR SCID-X1 IN LONG-TERM HEMATOPOIETIC STEM CELLS simplified abstract|18007439]])===


'''Main Inventor'''

Mara Pavel-Dinu


===METHODS RELATING TO ANTI-IL-1 THERAPY AND ANTI-IL-6 THERAPY AND HYPERSENSITIVITY ([[THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (18275474). METHODS RELATING TO ANTI-IL-1 THERAPY AND ANTI-IL-6 THERAPY AND HYPERSENSITIVITY simplified abstract|18275474]])===


'''Main Inventor'''

Vivian E. Saper


===MULTIPLE-FREQUENCY-COMPONENT SCANNING INVOLVING SCAN-PATTERN DESIGN AND BALANCED OR OPTIMIZED ATTRIBUTES ([[THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (18273735). MULTIPLE-FREQUENCY-COMPONENT SCANNING INVOLVING SCAN-PATTERN DESIGN AND BALANCED OR OPTIMIZED ATTRIBUTES simplified abstract|18273735]])===


'''Main Inventor'''

Zhanghao Sun


===BLOCKCHAIN SYSTEM FOR CONFIDENTIAL AND ANONYMOUS SMART CONTRACTS ([[THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (18515159). BLOCKCHAIN SYSTEM FOR CONFIDENTIAL AND ANONYMOUS SMART CONTRACTS simplified abstract|18515159]])===


'''Main Inventor'''

Shashank Agrawal